WOW....Thanks for that bigfella. I can't believe that anybody...

First 889 Last

Share
Profile

Follow
illdrink2that

1,409 Posts.

993

11/02/21

11:50

Post #: 50892283
Share

Originally posted by bigfella195: ↑

When the 1801 results were announced I was pleased that the primary endpoints had been achieved but was left with a few questions. I popped off an email to Botanix and this morning was able to get some answers. They could not have been any more open and forth coming, very appreciative. Thought I would share some insights:

- All 66 participants completed the trial. The participants were tested 3 times prior to the trial to determine if they had Staph Aureus. If they did not have a staph infection on the third test their data was not included and hence the percentages (A post yesterday clarified the calculations).

- There was no data collected at the end of day 5 as the trial was set up around the protocols of trials completed for other nasal decolonization products.

- 2 participants had MRSA, too few to be considered statistically significant. 1 in the vehicle group and 1 in the ointment group. The MRSA in the vehicle group was not eliminated, while the MRSA in the ointment group was successfully eliminated. Botanix had hoped there would be more MRSA cases.

- Side effects were really very mild, a little crustiness in some cases.

- The ASX no longer allow pharmaceutical companies to present comparisons with other company’s trials in announcements.

- The level of nasal staph was coded as eliminated, light, moderate or high. Data about staph levels in participants who were not classified as eliminated is still to come through.

- Participants who were recolognised by staph had there staph treated again and the staph was, in all cases, still susceptible suggesting no resistance development.

- In terms of recolognisation, staph is carried on many parts of the body and persistent carriers recolognize a lot. Other nasal decolonization studies gave participants full body chlorhexadine washes prior to the trial, something that was not done in Botanix’s trial.

- More data about the 1801 trial is still to come in.

-Matt Callaghan will be presenting remotely at a conference next week and hopefully will provide more data about the trial.

It is clear to me that Botanix genuinely believe the data is very good and compares well to competitors in the staph decolonization space, dialysis is one area they think this has some real potential.

My doubts about the results, based on some basic Google searches of other trials, were completely allayed. IMO Botanix is on to something and I’m not selling any time soon. Look forward to Matt’s presentation next week.

Expand

WOW....Thanks for that bigfella. I can't believe that anybody selling today has read your post. Talk about putting all the doubts to rest!
The sooner BOT release this info to the wider market the better. I suppose we may have to wait for Matt's conference next week, hopefully this will be recorded and available for all to view on the website?

BOT Price at posting: 14.0¢ Sentiment: Hold Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

KAU

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Superannuation Essentials: Building Wealth for Your Retirement

WTC

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

There are more pages in this discussion • 112 more messages in this thread...

First 889 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 34.5¢		Change 0.000(0.00%)		Mkt cap ! $627.0M

Open	High	Low	Value	Volume
34.5¢	35.5¢	34.5¢	$1.070M	3.066M

Buyers (Bids)

No.	Vol.	Price($)
14	194068	34.5¢

Sellers (Offers)

Price($)	Vol.	No.
35.0¢	116666	8

View Market Depth

No.	Vol.	Price($)
13	191068	0.345
21	614981	0.340
11	689342	0.335
15	522927	0.330
5	193945	0.325

Price($)	Vol.	No.
0.350	116666	8
0.355	363360	7
0.360	462643	10
0.365	139695	4
0.370	173000	4

Last trade - 16.10pm 21/10/2024 (20 minute delay)

BOT (ASX) Chart

WOW....Thanks for that bigfella. I can't believe that anybody...

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Superannuation Essentials: Building Wealth for Your Retirement

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

WOW....Thanks for that bigfella. I can't believe that anybody...

Top Stories

Bigtincan bounces 9% after $409M merger proposal sets stage for Nasdaq listing

Kaiser Reef sets up $8M capital raising to boost expansion at A1 gold mine

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Superannuation Essentials: Building Wealth for Your Retirement

A sex scandal is unlikely to hurt Australia's tech crown jewel – just look at trades

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News